Not Signed In -
Macular Degeneration |
|
|
Clinical Trial: A Study to Evaluate Retisert in the Treatment of Patients with the "wet" form of Age-Related Macular Degeneration
A Study to Evaluate Retisert in the Treatment of Patients with the "wet" form of Age-Related Macular Degeneration
This study is no longer recruiting patients.
|
Purpose
A study evaluating Retisert in patients with age-related macular degeneration
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Macular Degeneration | Drug: Retisert Implant | Phase II |
MedlinePlus related topics: Macular Degeneration
Study Type: Interventional
Study Design: Treatment
Further Study Details:
Study start: November 2001
Eligibility
Ages Eligible for Study: 55 Years and above, Genders Eligible for Study: Both
Location Information
Massachusetts
Control Delivery Systems, Inc., Watertown, Massachusetts, 02472, United States
More Information
Control Delivery Systems, Inc. Homepage
Information for Patients on AMD
Study ID Numbers: CDS FL-004
Record last reviewed: December 2002
Last Updated: October 13, 2004
Record first received: March 20, 2002
ClinicalTrials.gov Identifier: NCT00032396
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2002
Last Updated: October 13, 2004
Record first received: March 20, 2002
ClinicalTrials.gov Identifier: NCT00032396
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
